About

Travis Webb, Chief Scientific Officer, Pii, a Jabil company, has over 17 years of experience in both analytical and formulation contract development across multiple dosage forms including injectables, liquid pulmonary, oral solids and liquids, and topical drug products. During his career he has developed over 20 approved drug generic and NDA drug products and helped bring numerous INDs to various clinical stages.

Mr Webb also has extensive experience with quality by design and paediatric drug product development for both the US and Europe, supporting IND/NDA filings and communicating with regulatory agencies. He holds an MS in Pharmaceutical Chemistry from the University of Florida (US) and a BS in Biochemistry from Troy University (AL, US).

Contributions

EXPERT VIEW

DEVELOPMENTAL ADVANTAGES IN INJECTABLE COMBINATION DRUG PRODUCTS

Oliver Eden and Travis Webb consider how regulatory considerations and patient-centric device designs are transforming the landscape of self-administered injectable drugs.

More contributions

OCULAR

EXCIPIENT SELECTION FOR OPHTHALMIC OINTMENTS

Janice Cacace and Travis Webb describe the physical properties of petrolatums as they relate to the comfort and efficacy of formulations of ophthalmic ointments.